A critical review: serum cytokines and creatinine/cystatin C ratio as prognostic biomarkers in advanced cancer patients treated with anti-PD-1/PD-L1 therapy
Gespeichert in:
| Veröffentlicht in: | Supportive care in cancer 2024-08, Vol.32 (8), p.543, Article 543 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 8 |
| container_start_page | 543 |
| container_title | Supportive care in cancer |
| container_volume | 32 |
| creator | Uyar, Galip Can Çakmak Öksüzoğlu, Ömür Berna Sütcüoğlu, Osman |
| description | |
| doi_str_mv | 10.1007/s00520-024-08751-5 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3084028784</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3084028784</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-c06f0c2ee25d8281585f4866b8261edb7f3ac4c39ca8efa568e8cbecb4240efa3</originalsourceid><addsrcrecordid>eNp9kc9u1DAQxi0EokvhBTggS1y4mB3_Sxxu1ZYC0kpwgHPkOJPW7W6y2E6rfRcetrPdAhIHLh7P-Dff2P4Yey3hvQSolxnAKhCgjABXWynsE7aQRmtRa908ZQtojBRGW3vCXuR8DSDr2qrn7EQ3YCprmwX7dcZDiiUGv-EJbyPefeAZ07zlYV-mmzhi5n7sCUJf4kj5MuxzOez5iieKE_eZ79J0OU6ZdHgXp61PN5gyJ8b3t34MSAKHkPiOOnAsmZeDINXvYrmiCSWKb-dCLmlZS16uMPnd_iV7NvhNxleP8ZT9uPj4ffVZrL9--rI6W4ugVVVEgGqAoBCV7Z1y0jo7GFdVnVOVxL6rB-2DCboJ3uHgbeXQhQ5DZ5QBKuhT9u6oS8_4OWMu7TbmgJuNH3Gac6vBGVCudobQt_-g19OcRrrdAyWltCCJUkcqpCnnhEO7S5F-Zd9KaA_etUfvWvKuffCutdT05lF67rbY_2n5bRYB-ghkOhovMf2d_R_Zew7Ppns</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3084111501</pqid></control><display><type>article</type><title>A critical review: serum cytokines and creatinine/cystatin C ratio as prognostic biomarkers in advanced cancer patients treated with anti-PD-1/PD-L1 therapy</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Uyar, Galip Can ; Çakmak Öksüzoğlu, Ömür Berna ; Sütcüoğlu, Osman</creator><creatorcontrib>Uyar, Galip Can ; Çakmak Öksüzoğlu, Ömür Berna ; Sütcüoğlu, Osman</creatorcontrib><identifier>ISSN: 0941-4355</identifier><identifier>ISSN: 1433-7339</identifier><identifier>EISSN: 1433-7339</identifier><identifier>DOI: 10.1007/s00520-024-08751-5</identifier><identifier>PMID: 39046559</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>B7-H1 Antigen - blood ; Biomarkers, Tumor - blood ; Correspondence ; Creatinine - blood ; Cystatin C - blood ; Cytokines - blood ; Humans ; Immune Checkpoint Inhibitors - therapeutic use ; Medicine ; Medicine & Public Health ; Neoplasms - blood ; Neoplasms - drug therapy ; Nursing ; Nursing Research ; Oncology ; Pain Medicine ; Prognosis ; Programmed Cell Death 1 Receptor - antagonists & inhibitors ; Rehabilitation Medicine</subject><ispartof>Supportive care in cancer, 2024-08, Vol.32 (8), p.543, Article 543</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024</rights><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c326t-c06f0c2ee25d8281585f4866b8261edb7f3ac4c39ca8efa568e8cbecb4240efa3</cites><orcidid>0000-0002-2756-8646 ; 0000-0003-3835-2741 ; 0000-0002-0698-777X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00520-024-08751-5$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00520-024-08751-5$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39046559$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Uyar, Galip Can</creatorcontrib><creatorcontrib>Çakmak Öksüzoğlu, Ömür Berna</creatorcontrib><creatorcontrib>Sütcüoğlu, Osman</creatorcontrib><title>A critical review: serum cytokines and creatinine/cystatin C ratio as prognostic biomarkers in advanced cancer patients treated with anti-PD-1/PD-L1 therapy</title><title>Supportive care in cancer</title><addtitle>Support Care Cancer</addtitle><addtitle>Support Care Cancer</addtitle><subject>B7-H1 Antigen - blood</subject><subject>Biomarkers, Tumor - blood</subject><subject>Correspondence</subject><subject>Creatinine - blood</subject><subject>Cystatin C - blood</subject><subject>Cytokines - blood</subject><subject>Humans</subject><subject>Immune Checkpoint Inhibitors - therapeutic use</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Neoplasms - blood</subject><subject>Neoplasms - drug therapy</subject><subject>Nursing</subject><subject>Nursing Research</subject><subject>Oncology</subject><subject>Pain Medicine</subject><subject>Prognosis</subject><subject>Programmed Cell Death 1 Receptor - antagonists & inhibitors</subject><subject>Rehabilitation Medicine</subject><issn>0941-4355</issn><issn>1433-7339</issn><issn>1433-7339</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc9u1DAQxi0EokvhBTggS1y4mB3_Sxxu1ZYC0kpwgHPkOJPW7W6y2E6rfRcetrPdAhIHLh7P-Dff2P4Yey3hvQSolxnAKhCgjABXWynsE7aQRmtRa908ZQtojBRGW3vCXuR8DSDr2qrn7EQ3YCprmwX7dcZDiiUGv-EJbyPefeAZ07zlYV-mmzhi5n7sCUJf4kj5MuxzOez5iieKE_eZ79J0OU6ZdHgXp61PN5gyJ8b3t34MSAKHkPiOOnAsmZeDINXvYrmiCSWKb-dCLmlZS16uMPnd_iV7NvhNxleP8ZT9uPj4ffVZrL9--rI6W4ugVVVEgGqAoBCV7Z1y0jo7GFdVnVOVxL6rB-2DCboJ3uHgbeXQhQ5DZ5QBKuhT9u6oS8_4OWMu7TbmgJuNH3Gac6vBGVCudobQt_-g19OcRrrdAyWltCCJUkcqpCnnhEO7S5F-Zd9KaA_etUfvWvKuffCutdT05lF67rbY_2n5bRYB-ghkOhovMf2d_R_Zew7Ppns</recordid><startdate>20240801</startdate><enddate>20240801</enddate><creator>Uyar, Galip Can</creator><creator>Çakmak Öksüzoğlu, Ömür Berna</creator><creator>Sütcüoğlu, Osman</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2756-8646</orcidid><orcidid>https://orcid.org/0000-0003-3835-2741</orcidid><orcidid>https://orcid.org/0000-0002-0698-777X</orcidid></search><sort><creationdate>20240801</creationdate><title>A critical review: serum cytokines and creatinine/cystatin C ratio as prognostic biomarkers in advanced cancer patients treated with anti-PD-1/PD-L1 therapy</title><author>Uyar, Galip Can ; Çakmak Öksüzoğlu, Ömür Berna ; Sütcüoğlu, Osman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-c06f0c2ee25d8281585f4866b8261edb7f3ac4c39ca8efa568e8cbecb4240efa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>B7-H1 Antigen - blood</topic><topic>Biomarkers, Tumor - blood</topic><topic>Correspondence</topic><topic>Creatinine - blood</topic><topic>Cystatin C - blood</topic><topic>Cytokines - blood</topic><topic>Humans</topic><topic>Immune Checkpoint Inhibitors - therapeutic use</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Neoplasms - blood</topic><topic>Neoplasms - drug therapy</topic><topic>Nursing</topic><topic>Nursing Research</topic><topic>Oncology</topic><topic>Pain Medicine</topic><topic>Prognosis</topic><topic>Programmed Cell Death 1 Receptor - antagonists & inhibitors</topic><topic>Rehabilitation Medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Uyar, Galip Can</creatorcontrib><creatorcontrib>Çakmak Öksüzoğlu, Ömür Berna</creatorcontrib><creatorcontrib>Sütcüoğlu, Osman</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Supportive care in cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Uyar, Galip Can</au><au>Çakmak Öksüzoğlu, Ömür Berna</au><au>Sütcüoğlu, Osman</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A critical review: serum cytokines and creatinine/cystatin C ratio as prognostic biomarkers in advanced cancer patients treated with anti-PD-1/PD-L1 therapy</atitle><jtitle>Supportive care in cancer</jtitle><stitle>Support Care Cancer</stitle><addtitle>Support Care Cancer</addtitle><date>2024-08-01</date><risdate>2024</risdate><volume>32</volume><issue>8</issue><spage>543</spage><pages>543-</pages><artnum>543</artnum><issn>0941-4355</issn><issn>1433-7339</issn><eissn>1433-7339</eissn><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>39046559</pmid><doi>10.1007/s00520-024-08751-5</doi><orcidid>https://orcid.org/0000-0002-2756-8646</orcidid><orcidid>https://orcid.org/0000-0003-3835-2741</orcidid><orcidid>https://orcid.org/0000-0002-0698-777X</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0941-4355 |
| ispartof | Supportive care in cancer, 2024-08, Vol.32 (8), p.543, Article 543 |
| issn | 0941-4355 1433-7339 1433-7339 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3084028784 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | B7-H1 Antigen - blood Biomarkers, Tumor - blood Correspondence Creatinine - blood Cystatin C - blood Cytokines - blood Humans Immune Checkpoint Inhibitors - therapeutic use Medicine Medicine & Public Health Neoplasms - blood Neoplasms - drug therapy Nursing Nursing Research Oncology Pain Medicine Prognosis Programmed Cell Death 1 Receptor - antagonists & inhibitors Rehabilitation Medicine |
| title | A critical review: serum cytokines and creatinine/cystatin C ratio as prognostic biomarkers in advanced cancer patients treated with anti-PD-1/PD-L1 therapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T23%3A16%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20critical%20review:%20serum%20cytokines%20and%20creatinine/cystatin%20C%20ratio%20as%20prognostic%20biomarkers%20in%20advanced%20cancer%20patients%20treated%20with%20anti-PD-1/PD-L1%20therapy&rft.jtitle=Supportive%20care%20in%20cancer&rft.au=Uyar,%20Galip%20Can&rft.date=2024-08-01&rft.volume=32&rft.issue=8&rft.spage=543&rft.pages=543-&rft.artnum=543&rft.issn=0941-4355&rft.eissn=1433-7339&rft_id=info:doi/10.1007/s00520-024-08751-5&rft_dat=%3Cproquest_cross%3E3084028784%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3084111501&rft_id=info:pmid/39046559&rfr_iscdi=true |